Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea
· Delayed Price · Currency is KRW
9,790.00
-250.00 (-2.49%)
At close: Apr 28, 2026
KOSDAQ:014950 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 90,033 | 128,125 | - | - |
| Enterprise Value | 60,981 | 108,749 | - | - |
| Last Close Price | 9790.00 | 13970.00 | - | - |
| PS Ratio | 1.50 | 2.13 | - | - |
| PB Ratio | 1.31 | 1.86 | - | - |
| P/TBV Ratio | 1.31 | 1.87 | - | - |
| P/OCF Ratio | 43.36 | 61.70 | - | - |
| EV/Sales Ratio | 1.02 | 1.81 | - | - |
| EV/EBITDA Ratio | 13.12 | 23.39 | - | - |
| EV/EBIT Ratio | 18.63 | 33.23 | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.00 | 0.00 |
| Debt / EBITDA Ratio | 0.65 | 0.65 | 0.02 | 0.05 |
| Debt / FCF Ratio | - | - | 0.03 | 0.23 |
| Net Debt / Equity Ratio | -0.42 | -0.42 | -0.25 | -0.18 |
| Net Debt / EBITDA Ratio | -6.25 | -6.25 | -2.55 | -2.10 |
| Net Debt / FCF Ratio | 21.58 | 21.58 | -3.62 | -9.80 |
| Asset Turnover | 0.80 | 0.80 | 0.91 | - |
| Inventory Turnover | 1.31 | 1.31 | 1.56 | - |
| Quick Ratio | 3.51 | 3.51 | 2.09 | 2.03 |
| Current Ratio | 4.85 | 4.85 | 3.27 | 3.23 |
| Return on Equity (ROE) | -1.25% | -1.25% | 7.02% | - |
| Return on Assets (ROA) | 2.74% | 2.74% | 3.73% | - |
| Return on Invested Capital (ROIC) | -135.99% | -128.85% | 7.55% | 6.10% |
| Return on Capital Employed (ROCE) | 4.50% | 4.50% | 6.80% | 5.60% |
| Earnings Yield | -0.84% | -0.59% | - | - |
| FCF Yield | -1.50% | -1.05% | - | - |
| Payout Ratio | - | - | 7.98% | 4.73% |
| Buyback Yield / Dilution | -8.46% | -8.46% | -0.15% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.